Q3 2015 Holdings
Filed 2015-11-16 | 133 holdings | $2.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AbbVie Inc.(ABBV) | COM | 00287Y109 | $782.1M | 14,373,538 | 36.2% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $677.3M | 20,481,442 | 31.3% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $429.3M | 4,076,353 | 19.9% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $160.9M | 14,110,179 | 7.4% |
| Cerus Corporation(CERS) | COM | 157085101 | $61.5M | 13,553,275 | 2.8% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $22.0M | 7,335,692 | 1.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $7.7M | 435,540 | 0.4% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $7.1M | 100,000 | 0.3% |
| Incyte Corporation(INCY) | COM | 45337C102 | $2.1M | 19,474,969 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $1.4M | 36,029,746 | 0.1% |
| Cellectis S.A.(CLLS) | SPONSORED ADS | 15117K103 | $1.3M | 50,000 | 0.1% |
| Adaptimmune Therapeutics plc ADR(ADAPY) | SPONDS ADR | 00653A107 | $1.2M | 100,000 | 0.1% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $1.1M | 180,582 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $1.0M | 6,542,599 | 0.0% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $911.0K | 11,340 | 0.0% |
| Aldeyra Therapeutics, Inc.(ALDX) | COM | 01438T106 | $828.0K | 142,000 | 0.0% |
| Incyte Corporation Notes 1.25% 11/15/2020 144A | CONV BONDS | 45337CAL6 | $598.7K | $274,500,000 | 0.0% |
| Incyte Corporation Notes 0.375% 11/15/2018 144A | CONV BONDS | 45337CAK8 | $559.6K | $259,000,000 | 0.0% |
| Anacor Pharmaceuticals, Inc. | COM | 032420101 | $486.8K | 4,135,412 | 0.0% |
| Genomic Health Inc.(GHDX) | COM | 37244C101 | $289.0K | 13,658,328 | 0.0% |
| Clovis Oncology Inc. 2.5% 9/15/2021 | CONV BONDS | 189464AB6 | $215.3K | $129,300,000 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $194.4K | 5,462,019 | 0.0% |
| Dyax Corp. | COM | 26746E103 | $144.3K | 7,561,480 | 0.0% |
| BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | $115.6K | $22,379,000 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $101.7K | 2,955,074 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $94.9K | 6,747,332 | 0.0% |
| Gilead, Inc. 1.625% 5/1/16 | CONV BONDS | 375558AP8 | $90.3K | $20,944,000 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $71.0K | 2,907,784 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $60.9K | 4,190,594 | 0.0% |
| Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | CONV BONDS | 00484MAA4 | $54.1K | $59,583,000 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $52.7K | 1,262,382 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $47.3K | 6,554,967 | 0.0% |
| Versartis, Inc. | COM | 92529L102 | $37.4K | 3,241,783 | 0.0% |
| ImmunoGen, Inc.(IMGNEUR) | COM | 45253H101 | $34.1K | 3,548,040 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $29.9K | 750,739 | 0.0% |
| Insmed, Inc.(INSM) | COM PAR $.01 | 457669307 | $29.4K | 1,583,490 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $29.1K | 1,096,876 | 0.0% |
| Medivation, Inc. | COM | 58501N101 | $28.0K | 659,752 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $25.9K | 1,931,057 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $24.9K | 4,350,808 | 0.0% |
| Gilead Sciences, Inc.(GILD) | COM | 375558103 | $24.5K | 249,995 | 0.0% |
| Intra-Cellular Therapies, Inc.(ITCIEUR) | COM | 46116X101 | $24.4K | 609,166 | 0.0% |
| Zogenix, Inc. | COM NEW | 98978L204 | $24.3K | 1,798,365 | 0.0% |
| Exelisis, Inc. Notes 4.25% 8/15/2019 | CONV BONDS | 30161QAC8 | $24.0K | $20,000,000 | 0.0% |
| aTyr Pharma Inc.(LIFEUSD) | COM | 002120103 | $24.0K | 2,335,125 | 0.0% |
| Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | $23.4K | 6,976,162 | 0.0% |
| XenoPort, Inc. | COM | 98411C100 | $22.6K | 6,508,622 | 0.0% |
| Sangamo BioSciences, Inc.(SGMO) | COM | 800677106 | $21.2K | 3,755,876 | 0.0% |
| TG Therapeutics, Inc.(TGTX) | COM | 88322Q108 | $20.2K | 2,003,991 | 0.0% |
| Aegerion Pharmaceuticals, Inc. Notes 2.0% 8/15/2019 | CONV BONDS | 00767EAB8 | $19.9K | $26,517,000 | 0.0% |